EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Update current understanding of neurometabolic disorders related to lysine metabolism

Fu-Man Chang

Epilepsy & Behavior · 2023

DOI: 10.1016/j.yebeh.2023.109363 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Epilepsy & Behavior, 2023. Verfasst von Fu-Man Chang. Beteiligte Einrichtung: Department of Pediatrics, Taitung MacKay Memorial Hospital, Taitung, Taiwan. Electronic address: 2684.2684@mmh.org.tw. Hauptthemen laut MEDLINE: Epilepsy, Brain Diseases, Metabolic. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 85 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lysine, as an essential amino acid, predominantly undergoes metabolic processes through the saccharopine pathway, whereas a smaller fraction follows the pipecolic acid pathway. Although the liver is considered the primary organ for lysine metabolism, it is worth noting that lysine catabolism also takes place in other tissues and organs throughout the body, including the brain. Enzyme deficiency caused by pathogenic variants in its metabolic pathway may lead to a series of neurometabolic diseases, among which glutaric aciduria type 1 and pyridoxine-dependent epilepsy have the most significant clinical manifestations. At present, through research, we have a deeper understanding of the multiple pathophysiological mechanisms related to these diseases, including intracerebral accumulation of neurotoxic metabolites, imbalance between GABAergic and glutamatergic neurotransmission, energy deprivation due to metabolites, and the dysfunction of antiquitin. Because of the complexity of these diseases, their clinical manifestations are also diverse. The early implementation of lysine-restricted diets and supplementation with arginine and carnitine has reported positive impacts on the neurodevelopmental outcomes of patients. Presently, there is more robust evidence supporting the effectiveness of these treatments in glutaric aciduria type 1 compared with pyridoxine-dependent epilepsy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EpilepsyBrain Diseases, MetabolicGlutaryl-CoA DehydrogenaseLysineHumansAmino Acid Metabolism, Inborn Errors

Stichwörter der Autor:innen

Glutaric aciduria type 1Lysine metabolismLysine restrictionNeurometabolic disordersPyridoxine-dependent epilepsy

Substanzen

LysineGlutaryl-CoA Dehydrogenase

Autor:innen und Institutionen

  • Department of Pediatrics, Taitung MacKay Memorial Hospital, Taitung, Taiwan. Electronic address: 2684.2684@mmh.org.tw.

Zitieren

APA

Chang, F. M. (2023). Update current understanding of neurometabolic disorders related to lysine metabolism. Epilepsy & Behavior. https://doi.org/10.1016/j.yebeh.2023.109363

Vancouver

Chang FM. Update current understanding of neurometabolic disorders related to lysine metabolism. Epilepsy & Behavior. 2023. doi:10.1016/j.yebeh.2023.109363

BibTeX
@article{Chang2023,
  author = {Chang, Fu-Man},
  title = {Update current understanding of neurometabolic disorders related to lysine metabolism},
  journal = {Epilepsy & Behavior},
  year = {2023},
  doi = {10.1016/j.yebeh.2023.109363}
}
Kostenlos starten →